Matches in SemOpenAlex for { <https://semopenalex.org/work/W1889620811> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W1889620811 endingPage "51" @default.
- W1889620811 startingPage "343" @default.
- W1889620811 abstract "Neutral endopeptidase (NEP) is involved in the metabolism of atrial natriuretic peptide (ANP), whereas angiotensin-converting enzyme (ACE) is involved in the metabolism of angiotensin I; both enzymes participate in bradykinin metabolism. RB 105 is a new dual inhibitor which inhibits both peptidases, NEP (Ki = 1.7 nM) and ACE (Ki = 4.2 nM). In conscious spontaneously hypertensive rats (SHR), RB 105 i.v. dose-dependently decreased blood pressure and dose-independently caused natriuresis with dose-dependent increases in urinary cGMP and plasma renin concentration, and decrease in plasma ACE activity. RB 105 increased urinary excretion of both immunoreactive ANP and bradykinin. RB 105 completely blocked the hypertensive response of exogenous angiotensin I. Furthermore, RB 105 potentiated the hypotensive and natriuretic response to ANP and potentiated the hypotensive responses of bradykinin in SHR. Intravenous RB 105 decreased blood pressure similarly in DOCA-salt, renovascular (1C-2K) and spontaneously hypertensive rats and induced a similar natriuretic response in these three different renin-dependent and -independent models of hypertension. RB 105 also had hypotensive and natriuretic effects in normotensive rats. RB 105 also induced an increase in urinary excretion of cGMP and bradykinin and in plasma renin concentration in hypertensive and normotensive rats. In conclusion, RB 105 is a new dual inhibitor of ACE and NEP able to target both blood pressure and renal sodium handling in different experimental renin-dependent and -independent models of hypertension." @default.
- W1889620811 created "2016-06-24" @default.
- W1889620811 creator A5010061645 @default.
- W1889620811 creator A5012313192 @default.
- W1889620811 creator A5032132304 @default.
- W1889620811 creator A5048908246 @default.
- W1889620811 creator A5054483563 @default.
- W1889620811 creator A5074665989 @default.
- W1889620811 date "1995-01-01" @default.
- W1889620811 modified "2023-10-14" @default.
- W1889620811 title "Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats." @default.
- W1889620811 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7815350" @default.
- W1889620811 hasPublicationYear "1995" @default.
- W1889620811 type Work @default.
- W1889620811 sameAs 1889620811 @default.
- W1889620811 citedByCount "11" @default.
- W1889620811 countsByYear W18896208112018 @default.
- W1889620811 crossrefType "journal-article" @default.
- W1889620811 hasAuthorship W1889620811A5010061645 @default.
- W1889620811 hasAuthorship W1889620811A5012313192 @default.
- W1889620811 hasAuthorship W1889620811A5032132304 @default.
- W1889620811 hasAuthorship W1889620811A5048908246 @default.
- W1889620811 hasAuthorship W1889620811A5054483563 @default.
- W1889620811 hasAuthorship W1889620811A5074665989 @default.
- W1889620811 hasConcept C104826730 @default.
- W1889620811 hasConcept C126322002 @default.
- W1889620811 hasConcept C134018914 @default.
- W1889620811 hasConcept C138976137 @default.
- W1889620811 hasConcept C170493617 @default.
- W1889620811 hasConcept C174459258 @default.
- W1889620811 hasConcept C181199279 @default.
- W1889620811 hasConcept C185592680 @default.
- W1889620811 hasConcept C198710026 @default.
- W1889620811 hasConcept C27016395 @default.
- W1889620811 hasConcept C2778069365 @default.
- W1889620811 hasConcept C2779591629 @default.
- W1889620811 hasConcept C2779611605 @default.
- W1889620811 hasConcept C2908929049 @default.
- W1889620811 hasConcept C55493867 @default.
- W1889620811 hasConcept C71924100 @default.
- W1889620811 hasConcept C84393581 @default.
- W1889620811 hasConceptScore W1889620811C104826730 @default.
- W1889620811 hasConceptScore W1889620811C126322002 @default.
- W1889620811 hasConceptScore W1889620811C134018914 @default.
- W1889620811 hasConceptScore W1889620811C138976137 @default.
- W1889620811 hasConceptScore W1889620811C170493617 @default.
- W1889620811 hasConceptScore W1889620811C174459258 @default.
- W1889620811 hasConceptScore W1889620811C181199279 @default.
- W1889620811 hasConceptScore W1889620811C185592680 @default.
- W1889620811 hasConceptScore W1889620811C198710026 @default.
- W1889620811 hasConceptScore W1889620811C27016395 @default.
- W1889620811 hasConceptScore W1889620811C2778069365 @default.
- W1889620811 hasConceptScore W1889620811C2779591629 @default.
- W1889620811 hasConceptScore W1889620811C2779611605 @default.
- W1889620811 hasConceptScore W1889620811C2908929049 @default.
- W1889620811 hasConceptScore W1889620811C55493867 @default.
- W1889620811 hasConceptScore W1889620811C71924100 @default.
- W1889620811 hasConceptScore W1889620811C84393581 @default.
- W1889620811 hasIssue "1" @default.
- W1889620811 hasLocation W18896208111 @default.
- W1889620811 hasOpenAccess W1889620811 @default.
- W1889620811 hasPrimaryLocation W18896208111 @default.
- W1889620811 hasRelatedWork W1889620811 @default.
- W1889620811 hasRelatedWork W1997049660 @default.
- W1889620811 hasRelatedWork W1998933608 @default.
- W1889620811 hasRelatedWork W2039194724 @default.
- W1889620811 hasRelatedWork W2050645923 @default.
- W1889620811 hasRelatedWork W2124667595 @default.
- W1889620811 hasRelatedWork W2140623390 @default.
- W1889620811 hasRelatedWork W2141208096 @default.
- W1889620811 hasRelatedWork W2273726813 @default.
- W1889620811 hasRelatedWork W2283829801 @default.
- W1889620811 hasVolume "272" @default.
- W1889620811 isParatext "false" @default.
- W1889620811 isRetracted "false" @default.
- W1889620811 magId "1889620811" @default.
- W1889620811 workType "article" @default.